Feb. 7 (Bloomberg) -- Teva Animal Health, a unit of Teva Pharmaceutical Industries Ltd., said it will resume the manufacture and distribution of non-sterile liquid products after receiving approval to do so from the U.S. Food and Drug Administration. The company made the announcement in an e-mailed statement today.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Susan Lerner at slerner2@bloomberg.net